Flu in Biological Technology

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

MADISON, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to the...

Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain

ROCKVILLE, Md., June 30 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today its initial agreement to license its proprietary, recombinant virus-like-particle (VLP) vaccine technology to ROVI Pharmaceuticals (Madrid: ROVI) of Spain. ROVI will use the VLP technology to create ...

Australia: Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight

HONG KONG, June 11 /PRNewswire-Asia/ -- With a four-fold increase in swine flu cases within the last week, Filligent, the Australian-led biotech company, is mobilizing stocks of its anti-infective BioMask to help combat the spread of Influenza A (H1N1) across Australia. The BioMask is the firs...

Mach One Corporation Developing a Nasal, Hand Carried Product as Solution to Swine Flu (H1N1) Virus

Product Will Create A Barrier To Block The Attachment Of The Virus To The Nasal Membranes BELGIUM, Wis., June 4 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), an innovative, global wellness solutions company, announces the development of a nasal immunoglobulins based pr...

SANYO Donates Air Purification Systems Effective Against Flu Viruses to New York Airports and Schools

Some Recipients have recently faced H1N1 Flu Outbreaks JAMAICA, N.Y., May 26 /PRNewswire/ -- SANYO Biomedical and Environmental Solutions (SANYO), a division of SANYO North America, announces the donation of professional-use air purification systems to provide an added level of safe, healthy ...

CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology

VIENNA, Va. May 26 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE AMEX: CVM ) announced today that it is developing an immune-based treatment for the "swine flu and related H1N1" flu viruses, utilizing its proprietary L.E.A.P.S.(TM) (Ligand Epitope Antigen Presentation System) vaccine tec...

Vaxart Begins Animal Testing of H1N1 Flu Vaccine Candidate

SAN FRANCISCO, May 26 /PRNewswire/ -- Vaxart, Inc., a biotechnology company focused on the development of oral vaccines, announced today that the company has created a candidate vaccine for H1N1 influenza (swine flu). On Saturday, May 23, Vaxart began testing for immune responses in animals, just ...

Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data

Boston-based biotech firm Replikins Ltd. ( www.replikins.com ) last week analyzed the most recent peptide genomic sequence data available and determined that the infectivity of the H1N1 virus will increase markedly, while its lethality will remain relatively low for the immediate future. The comp...

AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1

CARLSBAD, Calif., May 21 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that a Canadian team comprised of the Canada Research Chair in Medical Genomics, Professor Jacques Corbeil and Canada Research Chair on new viruses and antiviral res...

Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again

MEMPHIS, Tenn., May 5 /PRNewswire/ -- UV germicidal lamps have been used to control outbreaks of measles, mumps, flu and other airborne respiratory illnesses in schools and hospitals since the 1930's. UVGI (Ultraviolet Germicidal Irradiation) systems successfully reduced infections in Mexican scho...

Meso Scale Diagnostics' Point of Care Influenza Test Led to the First Identification of A(H1N1) Swine Flu Infection

GAITHERSBURG, Md., May 4 /PRNewswire/ -- Meso Scale Diagnostics, LLC. (MSD) confirmed today that its investigational influenza test was used in detecting the first identified case of infection with the 2009 A(H1N1) swine flu. The MSD(R) Point of Care Influenza Test, which is being developed under...

First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide

LONDON, May 4 /PRNewswire/ -- A synthetic peptide H1N1 vaccine is available now for testing worldwide, from Replikins Ltd. The company has developed the vaccine based on the same Replikins peptide technology which provided the surprise advance warning one year ago that the current H1N1 outbreak/pa...

Sinovac Initiates Preparatory Activities for Swine Flu Vaccine

BEIJING, April 30 /PRNewswire-FirstCall/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, today announced that the Company has initiated preparatory activities for the development of a vaccine for the new influenza A (H1N1) strain, Swine Flu, whic...

Swine Flu a Reminder: Using Hand Sanitizers Like Remi-D Helps Fight Infection

No Alcohol, All-Natural Formula Avoids Pitfalls of Alcohol-Based Sanitizers CHARLOTTE, N.C., April 30 /PRNewswire/ -- When widespread illness hits, it's easy for individuals to feel helpless to protect themselves and their loved ones. Fortunately, an important way to prevent infection and the...

MMR Offers Free Surgical Masks to Call Attention to Importance of Personal Health Records in Preparing for Possible Swine Flu Pandemic

LOS ANGELES, April 28 /PRNewswire-FirstCall/ -- MMR Information Systems (OTC Bulletin Board: MMRF), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides Web-based consumer-controlled Personal Health Records ("PHRs") ( www.mymedicalrecords.com ...

Medicago initiates work on Swine Flu strain

QUEBEC CITY, April 28 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has received a genetic sequence...

Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA

DALLAS, April 28 /PRNewswire/ -- BeaconEquity.com announces the availability of Stock Alerts on stocks making news today. As the influenza dominates the headlines, several biopharmaceutical stocks are parading up the charts. So how does swine flu affect the markets? Check out a video chart f...

Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009

Novavax uses strategies to create vaccines for avian flu through genetically-engineered virus-like particles (VLPs) ROCKVILLE, Md., Nov. 13 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today that its strategy for treating avian flu through genetically-engine...

MultiVu Video Feed: New Rapid Test to Diagnose Flu May Help With Upcoming Flu Season

3M(TM) Rapid Detection Flu A+B Test Differentiates Flu Strains A & B In 15 Minutes Each year up to 20 percent of the U.S. population becomes ill with "the flu." Misdiagnosis of the flu is common as some bacterial infections present similarly to influenza. Because of this, overuse and unneces...

Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies

- Using proprietary platform, company develops first orally-administered vaccine to protect against avian influenza in a large-animal model - SAN FRANCISCO, Oct. 24 /PRNewswire/ -- Vaxart Inc., a biotechnology company focused on the development of oral vaccines, today announced positive effic...

Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents

Supports use of AHCC for immune enhancement during cold & flu season PURCHASE, N.Y., Sept. 24 /PRNewswire/ -- A new paper published in Nutrition Reviews (Vol. 66(9):526-531) by Dr. Barry W. Ritz, PhD, Department of Bioscience and Biotechnology at Drexel University, has shown how AHCC impacts...

Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season

BEIJING, Sept. 10 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced the market launch of Anflu(R), a seasonal influenza vaccine, for 2008-2009 Flu Season. Developed and manufactured by Sinovac, Anflu(R) is the only split influenza...

Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration

- Human Trials to Begin Later This Year - Only Nasal Powder Bird Flu Vaccine Under Development - Patient-Friendly (No Needles); No Preservatives - Stable at Room Temperature For 3 Years; No Cold Chain Distribution Required IRVIN...

High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu

HONG KONG, July 6 /PRNewswire-Asia/ -- Beginning today, Hong Kong people and their children will have direct access to Filligent's patented anti- microbial face mask, the BioMask(TM). The revolutionary mask, which traps and kills germs like H1N1 upon contact, was launched at Asia's leading dru...

NC Biomanufacturers Supply Defense for World vs. Flu

Huge GSK, Novartis, Merck plants help define state's economic successes RESEARCH TRIANGLE PARK, N.C., April 29 /PRNewswire-USNewswire/ -- The global fight against swine flu is shining a spotlight on North Carolina's long-term commitment to biomanufacturing. Global pharmaceutical giant Gl...

New strategies against bird flu

The Spanish flu outbreak of 1918 killed between 30 and 50 million people. In the infected patients, the ultimate cause of death was acute respiratory distress syndrome (ARDS). This fatal condition is a massive reaction of the body during which the lung becomes severely damaged. ARDS can be induced...

Kiwa Bio-Tech Joint Venture to Produce Preventative for Avian Flu

Kiwa Bio-Tech & Hebei Huaxing Pharmaceuticals Co., Ltd form Hebei Kiwa Huaxing Bio-Pharmaceuticals Co., Ltd. BEIJING and CLAREMONT, Calif., May 27 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced entry into a contra...

MIT explains spread of 1918 flu

CAMBRIDGE, Mass.--MIT researchers have explained why two mutations in the H1N1 avian flu virus were critical for viral transmission in humans during the 1918 pandemic outbreak that killed at least 50 million people. The team showed that the 1918 influenza strain developed two mutations in a sur...

Prodesse gets new funding; improves flu assay

Waukesha, Wis. -- Prodesse, Inc. announced Monday that it has received additional business investment and that it has completed a major process improvement to its ProFlu-1 assay. The company reported that a group of its core investors, plus three new accredited individuals, have provided an...

Wisconsin stands at the center of scientific efforts to avert flu epidemics

Welcome to Wisconsin, the flu capital of North America. Don't take that title the wrong way and run screaming for the nearest border. Wisconsin has yet to become a hot spot for the spread of avian influenza and, it can be hoped, won't become one. However, it may be the place where a possible...

UW shows why avian flu hasn't spread among humans yet

Although more than 100 people have been infected with the H5N1 avian influenza virus, mostly from close contact with infected poultry, the fact that the virus does not spread easily from its pioneering human hosts to other humans has been a biomedical puzzle. Now, a study of cells in the human r...

Preparing for avian flu with information technology

Avian flu is the newest threat to our safety. We know its strengths, its weaknesses, where it travels and what it looks like. Yet, with all we know about it, we can't prevent it. We can only prepare for its arrival, and with IT, we can aim to temper its effects. The Pandemic Influenza Plan pr...

Prodesse begins clinical trials for flu virus detection

Waukesha, Wis. - Several major healthcare institutions have begun clinical trials on a flu detection product developed by Prodesse, Inc. , a Waukesha-based biotechnology company. The product, known as ProFlu+, is being billed as a more complete and user-friendly test to help laboratories det...

New Mexico firm to make flu vaccine at Wisconsin BioManufacturing facility

Madison, Wis. - CytoDyn , a New Mexico-based biotechnology company, has selected the Waisman Clinical Bio-Manufacturing facility to manufacture its DNA-based, pre-flu vaccine. Located at the University of Wisconsin-Madison's Waisman Center , the biomanufacturing facility is designed to m...

EraGen diagnostic passes UW tests, could quickly detect bird flu

Madison, Wis. A new diagnostic tool that might play an important role in rapidly detecting viruses that cause avian flu and other respiratory illnesses is close to passing a validation test being conducted at University of Wisconsin Hospital and Clinics. The MultiCode panel technology, which ...

IT may take a back seat in fighting avian flu

Madison, Wis. Household planning will accomplish more in preparing for the eventual spread of a virulent strain of avian flu than will any reliance on information technology, attendees of WTN Media's Digital Healthcare Conference were told. Panelists talked about being three years late in d...

UW compound counters Avian flu

Madison, Wis. - Federal health officials may not be saying it, but they are frightened to death of the following scenario: an outbreak of the deadly avian flu virus begins quietly in scattered areas of the country, and spreads before they can get a handle on it - with substantial harm done to pub...

Medical College team creates website for tracking flu

Milwaukee, Wis. - To meet a growing bioinformatics challenge, a free website has been developed by a multidisciplinary team from the Medical College of Wisconsin and Children's Research Institute in Milwaukee to significantly improve diagnostic testing and worldwide genetic tracking of human an...

Novavax Reports Second Quarter 2009 Financial Results

...sults from the Phase II trial in healthy adults with our trivalent seasonal flu vaccine candidate; Initiate a Phase II clinical study of our trivalent seasonal flu vaccine in older adults; Continue development of our pandemic H1N1 va...

Next Safety Releases Advanced Respirator for Infectious Diseases

...r sale to the public respirator products the company developed for the bird flu influenza A subtype H5N1. The respirators were originally developed for the bird flu (H5N1), which never became contagious. The Next Safety respirators are now ...